BMSYX
Price
$14.62
Change
-$0.25 (-1.68%)
Updated
Aug 1 closing price
Net Assets
1.7B
VIMSX
Price
$76.99
Change
-$1.01 (-1.29%)
Updated
Aug 1 closing price
Net Assets
192.45B
Interact to see
Advertisement

BMSYX vs VIMSX

Header iconBMSYX vs VIMSX Comparison
Open Charts BMSYX vs VIMSXBanner chart's image
MFS Blended Research Mid Cap Eq R6
Price$14.62
Change-$0.25 (-1.68%)
VolumeN/A
Net Assets1.7B
Vanguard Mid Cap Index Investor
Price$76.99
Change-$1.01 (-1.29%)
VolumeN/A
Net Assets192.45B
BMSYX vs VIMSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BMSYX vs. VIMSX commentary
Aug 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMSYX is a Hold and VIMSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 192B vs. BMSYX (1.7B). VIMSX pays higher dividends than BMSYX: VIMSX (1.37) vs BMSYX (0.90). BMSYX was incepted earlier than VIMSX: BMSYX (9 years) vs VIMSX (27 years). BMSYX (0.58) is less costly to investors than VIMSX (0.17). BMSYX is a more actively managed with annual turnover of: 75.00 vs. VIMSX (16.00). BMSYX has a lower initial minimum investment than VIMSX: BMSYX (0) vs VIMSX (3000). VIMSX annual gain was more profitable for investors over the last year : 13.69 vs. BMSYX (-0.27). VIMSX return over 5 years is better than : 63.22 vs. BMSYX (32.69).
BMSYXVIMSXBMSYX / VIMSX
Total Expense Ratio0.520.17306%
Annual Report Gross Expense Ratio0.580.17341%
Fund Existence9 years27 years-
Gain YTD3.2496.88947%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.7B192B1%
Annual Yield % from dividends0.901.3765%
Returns for 1 year-0.2713.69-2%
Returns for 3 years24.0932.1975%
Returns for 5 years32.6963.2252%
Returns for 10 yearsN/A124.40-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RARE28.441.12
+4.10%
Ultragenyx Pharmaceutical
CPHC18.41N/A
N/A
Canterbury Park Holding Corp
ESS256.72-3.46
-1.33%
Essex Property Trust
VINP9.48-0.16
-1.66%
Vinci Compass Investments Ltd
LMFA1.99-0.13
-6.13%
LM Funding America